medigraphic.com

2020, Number 6

<< Back Next >>

Rev Fac Med UNAM 2020; 63 (6)

Electroconvulsive Therapy Overview: Indications and How it Works

Lamas ARM, Colín PR, González AA

Language: Spanish
References: 33
Page: 20-30
PDF size: 449.26 Kb.


ABSTRACT

The electroconvulsive therapy (ECT) constitutes one of the many treatment modalities available for management of psychiatric illnesses like depression, mania, schizophrenia, and catatonic states. It is even considered the single most effective and fastest treatment modality for patients with conditions like antidepressant-resistant depression, recurring suicidal ideations, acute psychoses, and potentially fatal conditions like malignant neuroleptic syndrome. ECT is a brain-stimulation therapy in which the therapeutic goal can be achieved through generating an electrical stimulus with enough intensity to produce a controlled seizure, achieving a positive and favorable neurobiological and neurochemical response.
This article focuses on the use of ECT in treating the various neuropsychiatric conditions, its pathophysiological principles, the employed technique, its main complications and overall a description of its use, its efficiency and safety, as to the experience of its employment in our institution. This comprises one of the few articles in Mexico with this kind of content that we deem fundamental as part of the general knowledge for healthcare professionals.


REFERENCES

  1. Riley A. Por qué existe el estigma contra la terapia de electroshock pese a ser eficaz contra la depresión profunda (y 10 veces menos peligrosa que un parto). British Broadcasting Corporation; 2018. Disponible en: https://www. bbc.com/mundo/vert-fut-45008327

  2. Mankad M, Beyer J, Weiner R, Krystal A. Clinical Manual of Electroconvulsive Therapy. First Edition. Washington, DC; London England: American Psychiatric Publishing, Inc; 2010.

  3. Fink M. Induced Seizures as Psychiatric Therapy Ladislas Meduna’s Contributions in Modern Neuroscience. The Journal of ECT. 2004;134-6.

  4. Hurtado-Puerto AM, Fernandez-Robles CG, Henry ME, Cusin C, Berg S, Camprodon JA. Electroconvulsive Therapy and Neurotherapeutics. En: Stern T, Freudenreich O, Smith F, Fricchione G, Rosenbaum J. Massachusetts General Hospital Handbook of General Hospital Psychiatry. Seventh Edition. Boston MA, USA: Elsevier; 2017. p. 405-11.

  5. Lisanby, S. Electroconvulsive Therapy for Depression. The New England Journal of Medicine, 2007;357:1939-1945.

  6. National Institute for Health and Care Excellence. Guidance on the use of electroconvulsive therapy; 2010. Disponible en https://www.nice.org.uk/guidance/ta59

  7. Ángeles, I. Empleo de la terapia electroconvulsiva en la unidad de neuropsiquiatría “Emil Kraepelin” de enero de 2012 a mayo de 2018. Tesis de especialidad para Especialidad en Medicina (Psiquiatría), 2018.

  8. Sienaert P, Dierick M, Degraeve G, Peuskens J. Electroconvulsive therapy in Belgium: a nationwide survey on the practice of electroconvulsive therapy. J Affect Disord. 2006;90(1):67-71.

  9. Vera I, Sanz-Fuentenebro J, Urretavizcaya M, et al. Electroconvulsive Therapy Practice in Spain: A National Survey. J ECT. 2016;32(1):55-61.

  10. Chanpattana W, Kramer BA, Kunigiri G, Gangadhar BN, Kitphati R, Andrade C. A survey of the practice of electroconvulsive therapy in Asia. J ECT. 2010;26(1):5-10.

  11. Gazdag G, Dragasek J, Takács R, et al. Use of Electroconvulsive Therapy in Central-Eastern European Countries: an Overview. Psychiatr Danub. 2017;29(2):136-140.

  12. American Psychiatric Association. La práctica de la terapia electroconvulsiva. Recomendaciones para el tratamiento, formación y capacitación. Primer Edición. Barcelona: Arsmedica, 2002.

  13. Kellner CH. ECT Technique. Handbook of ECT: A Guide to Electroconvulsive Therapy for Practitioners. Cambridge: Cambridge University Press; 2018. p. 49-86.

  14. Nuningaa JO. Claessensb TF. Somersb M, Mandlb R. Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder. Journal of Affective Disorders, 2018; 238:659-65.

  15. Organización Mundial de la Salud. Manual de Recursos de la OMS sobre Salud Mental, Derechos Humanos y Legislación. Ginebra, Suiza: Organización Mundial de la Salud; 2006.

  16. Liaqat J, Javed MU, Naseem A, Raja W, Wali W. Electroconvulsive therapy (ECT) for the management of neuroleptic malignant syndrome (NMS) in adults. Pakistan Armed Forces Medical Journal. 2018;68(3):445-9.

  17. Medda P, Toni C, Luchini F, Mariani MG, Mauri M, Perugi G. Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy. Bipolar Disorders. 2015;17(8):892-901.

  18. Latha Nagalla M, Akinyemi E, Hosanagar A, Demskey P, Nafiu I. Manic Delirium - Treatment Considerations. American Association for Geriatric Psychiatry Annual Meeting. 2014;22:3.

  19. Williams N, Bentzley B, Sahlem G, Pannu J, Korte J, Revuelta G. Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson’s disease. Acta neurologica Scandinavica. 2017;135(4):407-11.

  20. Andersen K, Balldin J, Gottfries CG. Granerús AK, Modigh K. A double‐blind evaluation of electroconvulsive therapy in Parkinson’s disease with “on‐off” phenomena. Acta Neurológica Escandinávica. 1987;76(3):191-9.

  21. Bennett HA, Einarson A. Prevalence of depression during pregnancy: systematic review. American College of Obstetricians and Gynaecologists. 2004;103(4):698-709.

  22. Bulbul F, Copoglu US, Alpak G, Unal A, Demir B, Tastan MF, Savas HA. Electroconvulsive therapy in pregnant patients. General Hospital Psychiatry. 2013;35(6):636-9.

  23. Freeman B. Pathway to Electroconvulsive Treatment for Minors. Child and Adolescent Psychiatric Clinics of North America. 2018;28(1):1-19.

  24. Jordão J, Ayala-Grosso C, Kelly M, Huang Y, Chopra R, McLaurin J, et al. Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-β Plaque Load in the TgCRND8 Mouse Model of Alzheimer’s Disease. Plos One. 2010;5(5):e10549.

  25. Ito M, Bolati K, Kinjo T, Ichimura K, Furuta A, Mc- Loughlin D, et al. Electroconvulsive stimulation transiently enhances the permeability of the rat blood-brain barrier and induces astrocytic changes. Brain Research Bulletin. 2017;(128):92-7.

  26. Lukoyanov NV, Sá MJ, Madeira MD, Paula-Barbosa MM. Selective loss of hilar neurons and impairment of initial learning in rats after repeated administration of electroconvulsive shock seizures. Experimental Brain Research. 2004;154(2):192-200.

  27. Bolwig T, Hertz M, Westergaard E. Acute hypertension causing blood-brain barrier breakdown during epileptic seizures. Acta Neurológica Escandinavica. 1977;56(4):335-42.

  28. Kazmierski R, Michalak S, Wencel-Warot A, Nowinski WL. Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology. 2012;79(16):1677-685.

  29. Salehi I, Mohammad S, Haghighi M, Jahangard L. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder. Journal of Psychiatric Research. 2016;76:1-8.

  30. Shirayama Y, Chen A C-H, Nakagawa S, Russell DS, Duman RS. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression. Journal of Neuroscience. 2002;22(8):3251-61.

  31. Lucassen PJ, Müller MB, Holsboer F, et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. American Journal of Pathology. 2001;158(2):453-68.

  32. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant- Like Effect of Brain-derived Neurotrophic Factor (BDNF). Pharmacology Biochemistry and Behavior. 1997;56(1):131-7.

  33. Abbott C, Jones T, Lemke Gallegos P, McClintock S, Mayer A, Bustillo J, Calhoun VD. Hippocampal structural and functional changes associated with electroconvulsive therapy response. Translational Psychiatry. 2014;4:e483.




2020     |     www.medigraphic.com